Aclaris Therapeutics logo
Aclaris Therapeutics ACRS
$ 2.78 0.33%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Aclaris Therapeutics EV/EBITDA Ratio 2011-2024 | ACRS

Annual EV/EBITDA Ratio Aclaris Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-9.24 -17.6 -0.216 -1.54 -8.53 -10.9 -6.12 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.216 -17.6 -7.74